Sofia

Sofia has emerged as a premier life sciences hub in South-Eastern Europe, renowned for its sophisticated blend of pharmaceutical manufacturing and cutting-edge biotechnology research.

The city is a global leader in clinical trial management, offering a robust infrastructure for Phase I-IV studies supported by a vast network of university hospitals and ICH-GCP compliant contract research organizations (CROs).

Sofia’s healthcare innovation ecosystem is anchored by the Bulgarian Academy of Sciences and prestigious medical universities, driving advancements in molecular biology, immunology and oncology.

The burgeoning medtech sector leverages the city’s deep talent pool in health informatics and AI-driven drug discovery to develop next-generation medical devices and digital health solutions.

Global biopharmaceutical companies are increasingly drawn to Sofia for its competitive operational costs and highly skilled workforce specializing in regulatory affairs and bioequivalence testing.

As a strategic gateway to the European market, the city fosters a collaborative environment where academic research and private enterprise accelerate the commercialization of life science technologies.

Sofia’s commitment to bio-innovation is further evidenced by its growing landscape of biotech incubators and specialized clinical research centers.

This dynamic ecosystem continues to attract significant foreign direct investment, solidifying Sofia’s position as a vital node in the global healthcare and life sciences value chain.